News Releases Year: All News201920182017201620152014201320122011 Items per page All News2550 June 21, 2019 Summary ToggleAllena Pharmaceuticals Showcases Reloxaliase and Enteric Hyperoxaluria Program at OHF International Hyperoxaluria Workshop Read more June 4, 2019 Summary ToggleAllena Pharmaceuticals Announces Interim Results from Study 206 of Reloxaliase in High Risk Patients with Advanced Oxalate Disorders Read more May 30, 2019 Summary ToggleAllena Pharmaceuticals to Present at Jefferies 2019 Healthcare Conference Read more May 8, 2019 Summary ToggleAllena Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Business Update Read more April 17, 2019 Summary ToggleAllena Pharmaceuticals Appoints Allene Diaz to its Board of Directors Read more March 27, 2019 Summary ToggleAllena Pharmaceuticals Announces Agreement with Duke Clinical Research Institute for URIROX-2 Pivotal Phase 3 Trial Read more March 7, 2019 Summary ToggleAllena Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update Read more March 5, 2019 Summary ToggleAllena Pharmaceuticals, Inc. to Present at 39th Annual Cowen & Co. Health Care Conference Read more January 4, 2019 Summary ToggleAllena Pharmaceuticals Announces Appointment of Louis Brenner, M.D. as Chief Executive Officer and Confirms Key Milestones for 2019 Read more January 2, 2019 Summary ToggleAllena Pharmaceuticals Achieves Alignment with FDA on Phase 3 Program and Accelerated Approval Pathway for Reloxaliase in Enteric Hyperoxaluria Read more Pagination Current page 1 Page 2 Page 3 Page 4 … Next page Next Last page Last
